[Renal function in white rats after tiroxin injection preceded by blockade of ACE and nitrogen oxide]

Aviakosmicheskaia I Ekologicheskaia Meditsina = Aerospace and Environmental Medicine
|August 22, 2008
PubMed

Insights

Thyroxine (T4) impacts kidney function, decreasing creatinine clearance and increasing protein excretion. Blocking nitric oxide (NO) synthesis or angiotensin-converting enzyme (ACE) with captopril alters these effects, highlighting complex renal responses.

Area of Science:

  • Nephrology
  • Endocrinology
  • Pharmacology

Background:

  • Thyroxine (T4) administration can influence renal function.
  • Nitric oxide (NO) and the renin-angiotensin-aldosterone system (RAAS) play critical roles in regulating kidney physiology.
  • Understanding the interplay between T4, NO, and ACE is crucial for managing renal health.

Purpose of the Study:

  • To investigate the effects of exogenous thyroxine (T4) on renal function in rats.
  • To examine how non-selective NO-synthase blockade or angiotensin-converting enzyme (ACE) inhibition modifies T4-induced renal changes.
  • To elucidate the specific roles of NO and ACE pathways in mediating T4's impact on the kidneys.

Main Methods:

  • Male Wistar rats were administered T4 intragastrically.
  • Animals were pre-treated with captopril (ACE inhibitor) or N(omega)-NLA (NO-synthase blocker).
  • Renal function was assessed by measuring urine and plasma osmolality, creatinine clearance, proteinuria, and nitrogen oxide levels.

Main Results:

  • T4 administration moderately decreased creatinine clearance and increased proteinuria, urinary osmolality, and excretion of nitrites and nitrates.
  • Captopril pre-treatment intensified diuresis but reduced the excretion of osmotically active substances (OAS) and nitrites in response to T4, without preventing reduced creatinine clearance or proteinuria.
  • NO synthesis pre-block significantly decreased creatinine clearance, OAS excretion, and nitrites, while moderating diuresis compared to T4-only treated rats.

Conclusions:

  • Exogenous thyroxine significantly alters renal function, impacting creatinine clearance, proteinuria, and nitrogen oxide metabolism.
  • The ACE pathway, while influencing diuresis and excretion, does not fully prevent T4-induced renal dysfunction.
  • NO synthesis inhibition markedly exacerbates T4-induced reductions in renal function, underscoring the protective role of NO in this context.

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...